Literature DB >> 6796130

The transfer of platelet factor 4 from its proteoglycan carrier to natural and synthetic polymers.

M Luscombe, S Marshall, D S Pepper, J J Holbrook.   

Abstract

1. Transfer of dansyl-platelet factor 4 complexed with a series of glycosaminoglycans to heparin has been detected and studied by measuring changes in the anisotropy of the dansyl fluorescence. The protein was most easily transferred from chondroitin sulphate and least easily from heparan sulphate. 2. The transfer of the dye-labelled protein from its biological chondroitin 4-sulphate proteoglycan carrier to natural and synthetic anionic polymers was similarily followed. The transfer to heparin and dermatan sulphate was shown to be the same whether 3 mM Ca2+ or 8 mM EGTA was present in the solution. 3. The shapes of the binding curves of the dansyl-factor to the polymers have been compared at I = 0.4M. 4. The observed changes in anisotropy of dye fluorescence have been correlated with the charge density and the stereochemistry of the charged groups of the natural polymers. Large complexes are observed with polymers of high negative charge/weight ratios. Less charged polymers containing disaccharide units of iduronic acid and glucosamine N-sulphate will also from large complexes at I = 0.15 M. 5. It is demonstrated that the release of a platelet factor 4 proteoglycan complex in vivo would result in the transfer of the protein to heparin, moderate quantities of either dermatan or heparan sulphates would not prevent this transfer.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6796130     DOI: 10.1016/0304-4165(81)90057-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Comparative studies of the interaction of human and bovine platelet factor 4 with heparin using histidine NMR resonances as spectroscopic probes.

Authors:  C J Talpas; L Lee
Journal:  J Protein Chem       Date:  1993-06

2.  Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.

Authors:  D A Lane; J Denton; A M Flynn; L Thunberg; U Lindahl
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

3.  Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor.

Authors:  J B Watson; S B Getzler; D F Mosher
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

4.  Binding of platelet factor 4 to heparin oligosaccharides.

Authors:  J Denton; D A Lane; L Thunberg; A M Slater; U Lindahl
Journal:  Biochem J       Date:  1983-02-01       Impact factor: 3.857

5.  Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia.

Authors:  M Margaret Prechel; Jeanine M Walenga
Journal:  Thromb J       Date:  2013-04-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.